Mitochondrial DNA depletion syndrome and its cardiac complication. [PDF]
Bao S +5 more
europepmc +1 more source
Mitochondrial diseases: from molecular mechanisms to therapeutic advances. [PDF]
Wen H +7 more
europepmc +1 more source
Exploring the Therapeutic Potential of Peritoneal Dialysis (PD) in the Treatment of Neurological Disorders. [PDF]
Cheng M, Ding Y, Kim E, Geng X.
europepmc +1 more source
Landscape of targets within nucleoside metabolism for the modification of immune responses. [PDF]
Dunderdale EM, Abt ER.
europepmc +1 more source
Thymidine phosphorylase in nucleotide metabolism: physiological functions and its implications in tumorigenesis and anti-cancer therapy. [PDF]
Huang B, Yuan Q, Sun J, Wang C, Yang D.
europepmc +1 more source
Genetic Diagnosis in Epilepsy: Implications for Clinical Management. [PDF]
Schatz KS, Lammert DB, Habela CW.
europepmc +1 more source
Mitochondrial Chronic Progressive External Ophthalmoplegia. [PDF]
Ali A, Esmaeil A, Behbehani R.
europepmc +1 more source
Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE-MTDPS1) [PDF]
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE-MTDPS1) is a devastating autosomal recessive disorder due to mutations in TYMP, which cause a loss of function of thymidine phosphorylase (TP), nucleoside accumulation in plasma and tissues, and mitochondrial dysfunction. The clinical picture includes progressive gastrointestinal dysmotility,
Alessandro Padovani +2 more
exaly +6 more sources
Distinctive gastrointestinal motor dysfunction in patients with MNGIE [PDF]
AbstractBackgroundMitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare mitochondrial disease caused by mutations in TYMP, encoding thymidine phosphorylase. Clinically it is characterized by severe gastrointestinal dysmotility associated with cachexia and a demyelinating sensorimotor polyneuropathy.
Carolina Malagelada +2 more
exaly +7 more sources

